1.
Indian J Dermatol Venereol Leprol
; : 1-2, 2024 Jul 09.
Article
in English
| MEDLINE
| ID: mdl-39152853
2.
3.
4.
5.
Indian J Dermatol Venereol Leprol
; 90(2): 256-257, 2024.
Article
in English
| MEDLINE
| ID: mdl-38595021
6.
Indian J Dermatol Venereol Leprol
; 90(1): 64-67, 2023.
Article
in English
| MEDLINE
| ID: mdl-37609736
7.
8.
9.
Indian J Sex Transm Dis AIDS
; 44(1): 105-106, 2023.
Article
in English
| MEDLINE
| ID: mdl-37457533
10.
Indian J Dermatol Venereol Leprol
; 89(2): 294-295, 2023.
Article
in English
| MEDLINE
| ID: mdl-35593278
11.
Indian J Sex Transm Dis AIDS
; 44(2): 187-188, 2023.
Article
in English
| MEDLINE
| ID: mdl-38223145
12.
13.
14.
PLoS Negl Trop Dis
; 16(4): e0010378, 2022 04.
Article
in English
| MEDLINE
| ID: mdl-35472087
15.
Int J Dermatol
; 61(7): e244-e245, 2022 07.
Article
in English
| MEDLINE
| ID: mdl-35187663
16.
Trop Doct
; 52(1): 226-227, 2022 Jan.
Article
in English
| MEDLINE
| ID: mdl-34787533
ABSTRACT
We read with interest the short report by Rani et al. entitled "An uncommon variant of erythema nodosum leprosum responding well to methotrexate: Report of two cases." The article describes two cases of erythema nodosum leprosum (ENL) with 'atypical features' and good response to low dose methotrexate. The authors address a few concerns regarding methotrexate in ENL, emphasizing the rational usage of this agent.
Subject(s)
Erythema Nodosum , Erythema Nodosum/diagnosis , Erythema Nodosum/drug therapy , Humans , Methotrexate/therapeutic use
17.
Indian J Sex Transm Dis AIDS
; 43(2): 224-226, 2022.
Article
in English
| MEDLINE
| ID: mdl-36743116
18.
Lancet Glob Health
; 9(4): e400-e401, 2021 04.
Article
in English
| MEDLINE
| ID: mdl-33740405
Subject(s)
Leprosy , Rifampin , Feasibility Studies , Humans , Leprosy/epidemiology , Leprosy/prevention & control , Post-Exposure Prophylaxis
19.
20.
Dermatol Ther
; 33(6): e14052, 2020 11.
Article
in English
| MEDLINE
| ID: mdl-32705770